ERNA vs VFC · P/E 0.0, rev $582.0K vs P/E 26, rev $9.50B
Eterna Therapeutics Inc (ERNA) versus VF Corporation (VFC) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
VF Corporation (VFC) is a apparel manufacturing company listed on NYSE.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported VFC revenue for 2025-03-29 was $9.50B. Net income was -$189.7M. Revenue was down 4.1% from 2024-03-30 to 2025-03-29. VFC currently screens at market cap $6.55B and trailing P/E 26.1.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. VFC currently screens at market cap $6.55B and trailing P/E 26.1.
Not investment advice. Open the ERNA and VFC stock pages for the full models.
Not investment advice.